Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity
- 29 July 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 15 (8) , 1205-1212
Abstract
The vast majority of tumor cells maintain the length of the telomeres through a telomerase-dependent maintenance mechanism, allowing for unlimited proliferation. TCAB1 is indispensable for the correct assembly of telomerase complexes and the delivery of telomerase to the telomere. Therefore, this study aimed to explore small molecules capable of interfering with the assembly of TCAB1 and the telomerase complex as novel efficient telomerase inhibitors. Through virtual screening, biological evaluation, and the confirmation of target engagement, the potential ligands of TCAB1 effectively inhibiting telomerase activity were discovered. Among them, compound 9 exhibited telomerase inhibitory activity at a two-digit nanomolar level (IC50 = 0.03 μM), which was dramatically enhanced in comparison with the previously reported telomerase inhibitors. This research, based on the blockage of telomerase assembly through disturbing TCAB1, provides a novel strategy and a potential target for telomerase inhibitor discovery.Keywords
Funding Information
- Anhui Provincial Department of Education (2023AH050855)
- Anhui University of Chinese Medicine (2021zrzd04)
- National Natural Science Foundation of China (22377001)
This publication has 22 references indexed in Scilit:
- Lead Optimization of BIBR1591 To Improve Its Telomerase Inhibitory Activity: Design and Synthesis of Novel Four Chemical Series with In Silico, In Vitro, and In Vivo Preclinical AssessmentsJournal of Medicinal Chemistry, 2023
- TCAB1 prevents nucleolar accumulation of the telomerase RNA to facilitate telomerase assemblyCell Reports, 2023
- Telomerase: A prominent oncological target for development of chemotherapeutic agentsEuropean Journal of Medicinal Chemistry, 2023
- Telomere Stress Potentiates STING-Dependent Anti-tumor ImmunityCancer Cell, 2020
- Targeting telomerase for its advent in cancer therapeuticsMedicinal Research Reviews, 2020
- Therapeutic strategies for targeting telomerase in cancerMedicinal Research Reviews, 2019
- An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1Cell, 2018
- Disease Association and Druggability of WD40 Repeat ProteinsJournal of Proteome Research, 2017
- Systematic analysis of telomere length and somatic alterations in 31 cancer typesNature Genetics, 2017
- WRAP53 promotes cancer cell survival and is a potential target for cancer therapyCell Death & Disease, 2011